Position in DERM
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$58,301
New position
Shares Held
12,431
first reported quarter
Ownership
0.044%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $106,800,407 across 37 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
512,924 | $26,877,217 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
20,421 | $11,064,710 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
51,732 | $8,718,911 | |
| 4 | ZTS |
Zoetis Inc.
|
108,947 | $7,828,931 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
224,462 | $7,782,097 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
68,281 | $7,575,094 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
240,384 | $5,915,850 | |
| 8 | VTRS |
Viatris Inc
|
266,382 | $4,230,146 |
All Filings in DERM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $58,301 | 12,431 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||